Dawei Yuan
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Circular RNAs in diseases 3
- Microbial Metabolic Engineering and Bioproduction 3
- RNA modifications and cancer 3
- Oncology 10
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Kun Zhu (19 shared papers)Chengxue Dang (15 shared papers)Rong Yan (9 shared papers)Kang Li (7 shared papers)Patricia Relue (2 shared papers)Kang Li (5 shared papers)Sasidhar Varanasi (2 shared papers)Yong Jia (2 shared papers)
- Journals
- Oncotarget (3 papers)BioMed Research International (2 papers)Bioresource Technology (2 papers)Frontiers in Oncology (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Dawei Yuan
46 papers receiving 758 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 246
- Oncology 148
- Molecular Biology 340
- Pharmacology 40
- Otorhinolaryngology 17
Countries citing papers authored by Dawei Yuan
This map shows the geographic impact of Dawei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Yuan more than expected).
Fields of papers citing papers by Dawei Yuan
This network shows the impact of papers produced by Dawei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Yuan. The network helps show where Dawei Yuan may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 69 | |
| 2 | 2023 | 57 | |
| 3 | 2014 | 51 | |
| 4 | Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway. | 2019 | 50 |
| 5 | 2004 | 48 | |
| 6 | 2018 | 39 | |
| 7 | 2020 | 39 | |
| 8 | 2013 | 38 | |
| 9 | 2012 | 35 | |
| 10 | 2010 | 33 | |
| 11 | 2018 | 32 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 27 | |
| 14 | 2018 | 22 | |
| 15 | 2020 | 16 | |
| 16 | 2021 | 15 | |
| 17 | 2020 | 14 | |
| 18 | 2012 | 12 | |
| 19 | 2021 | 10 | |
| 20 | 2023 | 10 |
About Dawei Yuan
Dawei Yuan is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Surgery, having authored 46 papers that have together received 766 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), MicroRNA in disease regulation (3 papers), Microbial Metabolic Engineering and Bioproduction (3 papers), RNA modifications and cancer (3 papers), Biofuel production and bioconversion (3 papers) and Natural Compounds in Disease Treatment (2 papers). The work is most often cited by research in Cancer Research (246 citations), Oncology (148 citations), Molecular Biology (340 citations), Pharmacology (40 citations) and Otorhinolaryngology (17 citations). Dawei Yuan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Kun Zhu, Chengxue Dang, Rong Yan, Kang Li, Patricia Relue, Kang Li, Sasidhar Varanasi, Yong Jia, Haonan Wang and Rong Yan. Their work appears in journals such as Oncotarget, BioMed Research International, Bioresource Technology, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.